关于《仿制药与参比制剂的可互换性：平均生物等效性方法的局限性》的评论 - Suppr

Suppr

超能文献

Comment on "Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology".

作者信息

Nicolas Patrick, Bertagna Xavier

机构信息

School of Medicine, Paris 13 University, Bobigny, France.

CHU Avicenne - Service de Biochimie - Pharmacologie, Bobigny, France.

出版信息

Eur J Drug Metab Pharmacokinet. 2023 Mar;48(2):213-215. doi: 10.1007/s13318-022-00814-4. Epub 2023 Jan 21.

DOI:10.1007/s13318-022-00814-4

PMID:36670339

Abstract

摘要

相似文献

Comment on "Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology".

Eur J Drug Metab Pharmacokinet. 2023 Mar;48(2):213-215. doi: 10.1007/s13318-022-00814-4. Epub 2023 Jan 21.

Response to Comment on "Interchangeability Between Generic and Reference Products: Limits of Average Bioequivalence Methodology".

Eur J Drug Metab Pharmacokinet. 2023 Mar;48(2):217-219. doi: 10.1007/s13318-022-00813-5. Epub 2023 Jan 21.

Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology.

Eur J Drug Metab Pharmacokinet. 2022 Nov;47(6):777-787. doi: 10.1007/s13318-022-00785-6. Epub 2022 Aug 19.

Assessing bioequivalence and drug interchangeability.

J Biopharm Stat. 2017;27(2):272-281. doi: 10.1080/10543406.2016.1265537. Epub 2016 Dec 9.

Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?

Acta Clin Belg. 2009 Sep-Oct;64(5):406-14. doi: 10.1179/acb.2009.067.

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs.

BMC Pharmacol Toxicol. 2017 Dec 8;18(1):78. doi: 10.1186/s40360-017-0182-1.

Comparison of scaled-average, population, and individual bioequivalence on 2 tablets of pitavastatin calcium: a 3-period, reference-replicated, crossover study in healthy Chinese volunteers.

Clin Ther. 2014 Sep 1;36(9):1205-1216.e6. doi: 10.1016/j.clinthera.2014.06.021.

Bioequivalence review for drug interchangeability.

J Biopharm Stat. 1999 Aug;9(3):485-97. doi: 10.1081/BIP-100101189.

Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia.

Br J Clin Pharmacol. 2019 Sep;85(9):2059-2065. doi: 10.1111/bcp.13997. Epub 2019 Jul 7.

Some thoughts on drug interchangeability.

J Biopharm Stat. 2016;26(1):178-86. doi: 10.1080/10543406.2015.1092027.

本文引用的文献

Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology.

Eur J Drug Metab Pharmacokinet. 2022 Nov;47(6):777-787. doi: 10.1007/s13318-022-00785-6. Epub 2022 Aug 19.

Association Between Generic-to-Generic Levothyroxine Switching and Thyrotropin Levels Among US Adults.

JAMA Intern Med. 2022 Apr 1;182(4):418-425. doi: 10.1001/jamainternmed.2022.0045.

Comment on "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".

Clin Pharmacokinet. 2020 Feb;59(2):281-282. doi: 10.1007/s40262-019-00850-5.

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Clin Pharmacokinet. 2020 Feb;59(2):265-267. doi: 10.1007/s40262-019-00847-0.

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Clin Pharmacokinet. 2020 Feb;59(2):273-275. doi: 10.1007/s40262-019-00849-y.

Comment on: "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".

Clin Pharmacokinet. 2019 Oct;58(10):1351-1352. doi: 10.1007/s40262-019-00814-9.

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?

Clin Pharmacokinet. 2020 Jan;59(1):1-5. doi: 10.1007/s40262-019-00812-x.

Comment on "Levothyrox New and Old Formulations: Are They Switchable for Millions of Patients?".

Clin Pharmacokinet. 2019 Jul;58(7):969-971. doi: 10.1007/s40262-019-00785-x.

Comment on: "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".

Clin Pharmacokinet. 2019 Jul;58(7):965-966. doi: 10.1007/s40262-019-00779-9.

Comment on: "Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?".

Clin Pharmacokinet. 2019 Jul;58(7):959-960. doi: 10.1007/s40262-019-00778-w.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验